FDA approval numbers soar after COVID troubles

The FDA released its overview of 2023 and the drugs it had approved during the year. Ben Hargreaves finds that the agency’s approval numbers have bounced back, after being substantially down in 2022, and that 2023 could be remembered due to some landmark approvals.